Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.


Kanmin holds dual roles as the NIHR Academic Clinical Lecturer, conducting laboratory and clinical research within the Clinical Ophthalmology Research Group of Professor Robert MacLaren, and as the Senior Specialty Registrar at the Oxford Eye Hospital, working towards completion of ophthalmic specialty training. He conducted PhD research at the MRC Laboratory of Molecular Biology in Cambridge, underwent clinical training at Trinity College, Cambridge, and pre-clinical training at Brasenose College, Oxford, where he was awarded top-First Class (Martin Wronker Prize) in Medicine.

Kanmin Xue

MA MB BChir PhD FRCOphth

Academic Clinical Lecturer in Ophthalmology

  • Honorary Specialty Registrar, Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust


Kanmin's research focuses on the development of gene therapy as a treatment for inherited diseases of the retina. In association with Professor Robert MacLaren, he is leading the clinical trial of gene therapy for choroideremia, a model genetic disorder that causes progressive blindness. He is also investigating the cellular responses to gene therapy viral vectors within the retina with a view to producing more potent and sustained therapeutic effects.

Team members

Laurel Chandler, DPhil student (Merton College, Oxford)

Howell Fu, FHS student 2015 (Exeter College, Oxford)

Olivia Parham, FHS student 2016 (New College, Oxford)

Key publications

Recent publications

More publications